Extremely grateful and honored to receive the @binaytara 2026 Impact Pitch Lung Cancer Research Award! 🫁🔬 This support will advance our NSCLC #IIT exploring gut microbiome modulation with #immunotherapy and establish a longitudinal multi-omic biobank. Sincere thanks to @binayshah, the Brooklyn Lung Cancer Conference team (@JSabari, Dr. Veluswamy @nyulangone), the Impact Pitch judges (@CoreyLangerMD, @VamsiVelcheti, @ShirishGadgeel & Dr. Cascone), and my mentors (@GlopesMd, @DionysiosWatson, @Latinamd, @DrTracyECrane) for believing in and supporting this research. The trial was developed through the @sitcancer Clinical Trial Workshop, with its multi-omic framework refined at the @AACR IME Workshop. @SylvesterCancer @HemOncMiami @univmiami #LungCancer #NSCLC #Immunotherapy #GutMicrobiome
13
9
69
8,478
In Atlanta at the @BAPSCharities Healthcare Professionals Conference, I spoke on "Precision Oncology 2026: 5 Things Every Physician Should Know" for clinicians from across medicine 🎤 Here are the highlights 🧵 @SylvesterCancer @GlopesMd @HemOncMiami @Latinamd @RamalingamMD
1
8
266
🍷 I ended with prevention. Our @ASCO 2025 study and recent publication @LancetRH_Americ found that the share of cancer deaths attributable to alcohol significantly went up in US adults 20 and older over 33 years, across breast, colorectal, liver, pancreatic, stomach, prostate and head and neck cancers. Prevention starts in primary care @GlopesMd @SylvesterCancer @CNN
1
18
🙏 Thank you @BAPSCharities for the invitation, and to my mentors and collaborators @GlopesMd @DrRanaMcKay @Latinamd @SylvesterCancer #lungcancer #LiquidBiopsy #PrecisionOncology
16
Next @BAPSCharities , the "Healing Beyond Borders" panel with @RamalingamMD, Dr. Patrick Lammie and Dr. Rakendu Shukla. @rakendus 🩺 Dr. Ramalingam's message was a powerful one: global impact starts in the clinic, with the patient in front of you. The time we spend with patients, listening to them and caring for them, is what shapes the work we go on to do at a national and global level. #GlobalHealth #Oncology
11
368
A morning at the @BAPSCharities Healthcare Professionals Conference, learning from leaders in the field 🌍 First up, AI in medicine 🤖 Dr. Anant Madabhushi @anantm @WinshipAtEmory shared an AI model that reads histology in seconds to guide breast cancer surgical margins. Exciting early work. @RamalingamMD @VamsiVelcheti 🧵
1
7
305
Chinmay Jani retweeted
Final day of #WCC26 #WorldCancerCongress. I had hoped to be in Hong Kong for Plenary 3, “Impact, Influence, and Societal Change,” but after returning home for family reasons I was grateful to contribute through recorded remarks.
2
4
517
Spent a day with faculty from across oncology and @MJHLifeSciences on how we engage the oncology community: research, med ed, fellows, trial training, patient education, AI and wellness. 🎙️ It brought back the on-camera media training a few months ago: communicating science well is a trainable skill. 🎂 And a happy birthday to @Jonathanwlee23, a great partner in med ed! @ginacolumbusonc @gachanta @GIMedOnc @DrShubhamPant @Neil_Iyengar @andrewlipskymd @SylvesterCancer
10
459
Chinmay Jani retweeted
Outstanding #GrandRounds by Dr. Coral Olazagasti, where she shared her diverse and impactful research portfolio! 🙌 Especially pleased to see her highlight her work around #LungCancerScreening w more inclusive guidelines across our diverse South Florida population! 🧡💚👏👏👏
1
9
34
1,982
Chinmay Jani retweeted
Going on now excellent and passionate @SylvesterCancer Heme-Onc Grand Rounds by @COlazagasti on #lungcancerscreening from Evidence to Equity. Showing impact of Studying the gaps in knowledge and implementation strategies to improve screening in underrepresented groups. #lcsm #lungscreening
9
14
829
Chinmay Jani retweeted
✈️ Made it to the Big 🍎 NYC for @OLNGreatDebates, starting tomorrow, Sept 26–27! My 2nd chance to argue that perioperative chemoimmunotherapy is better than preoperative therapy alone—this time against Dr. Jamie Chaft @MSKCancerCenter . 🥊 Let the best argument win! 🎤 #OLNGreatDebates @SylvesterCancer
2
3
26
906
Read our perspective @OncUpdates on the 7-year CROWN data and what the remarkable durability of systemic and intracranial disease control with lorlatinib means for the evolving first-line treatment landscape in ALK+ NSCLC. 🫁🧠 #LungCancer #NSCLC #ALK #PrecisionOncology #lcsm @SylvesterCancer @OncBrothers @Latinamd @GlopesMd @HemOncMiami
⭐️ #CROWN at 7 yrs: new benchmark for 1L #ALK+ #NSCLC 🫁Lorlatinib vs crizotinib ✅7-yr PFS 55% vs 3% 🧠No new intracranial progression after 30 mo (~92% IC-free at 7 yrs) @diya_jayram @Jani_Chinmay @HemOncMiami @GlopesMd #lcsm #LungCancer #OncTwitter oncupdates.com/article/crown…
3
10
915
Chinmay Jani retweeted
My take on Galleri @WSJ @WSJopinion “People differ in how they value earlier detection, uncertainty, diagnostic risk and out-of-pocket cost. Once regulators have judged the evidence sufficient for access, informed patients and their physicians should be able to examine these results and decide together. Approval need not mean universal screening. It should mean that government doesn’t substitute one national judgment for millions of individual decisions.” @SylvesterCancer @asco @myESMO @SclcSMASHERS @FDA @LUNGevity @lungoncdoc @StephenVLiu @HHorinouchi @g_mountzios @sands_jacob @LauraAlderMD @oncodaily @OncoAlert @Latinamd @LuisPaz_Ares @RManochakian @LuisRaezMD @triparnasen @LaurenByersMD @LungCancerEu @alissajcooper @BZhangMD @NaglaAKarimMD @Annechiangmd @IASLC @NCCN @ASCO #WCLC26 @larvol @tribeMDUS @sylvestercancer @oncbrothers @chinmay @Jani_Chinmay @colazagasti @openmedicineHQ @myesmo @openmedkate @openmedben @chadinabhan @YoungLungCancer @OncodailyLung @ClinicalLung #LCSM @LungPolicy @dan_morgen wsj.com/opinion/the-galleri-…
7
15
46
6,257
Chinmay Jani retweeted
Thanks to @medpagetoday for highlighting our @JCO_ASCO article. Need to write more soon on how primary palliative care looks/works in a busy oncology clinic. Shout out to my amazing clinic team (including Irena quoted) who are the reason we can provide this comprehensive care.
3
5
48
2,594
Alcohol remains an under-recognized - and modifiable - cancer risk. New data from our study @LancetRH_Americ show US alcohol-attributable cancer deaths doubled from 1990 to 2023. 🍷 Grateful that @FoxNews is helping bring attention to it; awareness really can lower risk. 🙏 #OncTwitter @GlopesMd @SylvesterCancer @MDRCollab @Latinamd foxnews.com/health/alcohol-t…
3
6
274